<DOC>
	<DOCNO>NCT01230619</DOCNO>
	<brief_summary>RV568 develop treatment disease asthma , COPD allergic rhinitis ( e.g . hayfever ) . The main aim study investigate whether RV568 ameliorate nasal symptom low dos grass pollen healthy subject seasonal allergic rhinitis .</brief_summary>
	<brief_title>Vienna Challenge Chamber Study Using RV658 Subjects With Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>Subject healthy History seasonal allergic rhinitis Male age 18 55 year Body weight &gt; /= 50 kg BMI range 19 29 kg/m2 ( inclusive ) Exhibits moderate response 4 hour exposure grass pollen challenge chamber total nasal symptom score ( TNSS ) &gt; /= 6 Positive skin prick test ( wheal &gt; /= 4 mm ) grass pollen Positive total IgE result ( RAST class &gt; /= 2 ) grass pollen Current nonsmoker use tobacco past 6 month pack history &lt; /= 10 pack year Baseline FEV1 &gt; /= 80 % FEV1/FVC &gt; /= 70 % predict value No condition factor may preclude subject ability remain challenge chamber period 6 hour capable give informed consent compliant protocol requirement available complete study measurement structural nasal abnormality nasal polyp , history frequent nosebleed , recent nasal surgery recent ( within 3 week ) ongoing upper respiratory tract infection history drug allergy participation another clinical trial participate study use NCE within previous 3 month , clinical study within 1 month take regular ( course ) medication whether prescribed , include steroid , vitamin , macrolides , antifungal agent herbal remedy . Paracetamol ( &lt; /= 2g / day ) occasional short act beta agonist permit use oral , injectable dermal steroid within 5 week intranasal and/or inhaled steroid within 1 week screen visit past present disease , judge investigator , may affect outcome study regular consumption &gt; 21 unit alcohol per week infect Hepatitis B , Hepatitis C , HIV virus current chronic history liver disease , know hepatic biliary abnormality positive test drug abuse alcohol screen previously know allergy active inactive ingredient study medication mentally legally incapacitated reason investigator considers make subject unsuitable participate</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>